Intelligent Bio Solutions Inc. Files 8-K
Ticker: INBS · Form: 8-K · Filed: Jan 31, 2025 · CIK: 1725430
Sentiment: neutral
Topics: 8-K, filing, financials
TL;DR
IBSI filed an 8-K on Jan 31, 2025, with Reg FD and financial updates.
AI Summary
Intelligent Bio Solutions Inc. filed an 8-K on January 31, 2025, reporting on Regulation FD disclosures and financial statements. The company, formerly known as GBS Inc., is incorporated in Delaware and headquartered in New York City.
Why It Matters
This filing provides important updates and disclosures for investors regarding Intelligent Bio Solutions Inc.'s regulatory compliance and financial status.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, indicating standard corporate reporting rather than a specific event with immediate high risk.
Key Players & Entities
- Intelligent Bio Solutions Inc. (company) — Registrant
- GBS Inc. (company) — Former company name
- Glucose Biosensor Systems (Greater China) Holdings, Inc. (company) — Former company name
- January 31, 2025 (date) — Date of report
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing serves as a Current Report for Intelligent Bio Solutions Inc., covering Regulation FD Disclosures and Financial Statements and Exhibits.
When was this 8-K report filed?
The report was filed on January 31, 2025.
What are the previous names of Intelligent Bio Solutions Inc.?
The company was formerly known as GBS Inc. and prior to that, Glucose Biosensor Systems (Greater China) Holdings, Inc.
Where is Intelligent Bio Solutions Inc. headquartered?
The company's principal executive offices are located at 135 West 41st Street, 5th Floor, New York, NY 10036.
In which state is Intelligent Bio Solutions Inc. incorporated?
Intelligent Bio Solutions Inc. is incorporated in Delaware.
Filing Stats: 537 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2025-01-31 17:15:25
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value INBS The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 37KB
- ex99-1.htm (EX-99.1) — 16KB
- ex99-1_001.jpg (GRAPHIC) — 31KB
- ex99-1_002.jpg (GRAPHIC) — 21KB
- 0001493152-25-004490.txt ( ) — 300KB
- inbs-20250131.xsd (EX-101.SCH) — 3KB
- inbs-20250131_lab.xml (EX-101.LAB) — 33KB
- inbs-20250131_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 31, 2025 INTELLIGENT BIO SOLUTIONS INC. By: /s/ Spiro Sakiris Name: Spiro Sakiris Title: Chief Financial Officer